TipRanks
Go Ultimate55% OFF

Verrica Pharmaceuticals (VRCA) Stock Forecast & Price Target

491 Followers
See the Price Targets and Ratings of:

VRCA Analyst Ratings

Strong Buy
4Ratings
3Buy1Hold0Sell
Based on 4 analysts giving stock ratings to Verrica Pharmaceuticals in the past 3 months

VRCA Stock 12 Month Forecast

$13.67▲(315.40% Upside)
Based on 4 Wall Street analysts offering 12 month price targets for Verrica Pharmaceuticals in the last 3 months. The average price target is $13.67 with a high forecast of $20.00 and a low forecast of $9.00. The average price target represents a 315.40% change from the last price of $3.29.
Highest Price Target$20.00Average Price Target$13.67Lowest Price Target$9.00

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for VRCA
Price TargetFollowArticle
H.C. Wainwright$12buy264.74%UpsideReiterated10/22/26
TD Cowen$20buy507.90%UpsideReiterated10/21/26
Lake Street$9buy173.56%UpsideReiterated10/01/26
Needham―hold―Reiterated08/27/26
Brookline Capital Markets$17buy416.72%UpsideUpgraded12/17/25
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
AXGNAxoGen
SLDBSolid Biosciences
AHCOAdaptHealth
ONCBeOne Medicines
ARDXArdelyx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Verrica Pharmaceuticals

3 Months
Stacy Ku
Stacy KuTD Cowen
Success Rate4/15 ratings generated profit
27%
Average Return
-10.99%

Copying Stacy Ku's trades and holding each position for 3 Months would result in 26.67% of your transactions generating a profit, with an average return of -10.99% per trade.

1 Year
Stacy Ku
Stacy KuTD Cowen
Success Rate1/15 ratings generated profit
7%
Average Return
-45.00%

Copying Stacy Ku's trades and holding each position for 1 Year would result in 6.67% of your transactions generating a profit, with an average return of -45.00% per trade.

2 Years
Stacy Ku
Stacy KuTD Cowen
Success Rate0/15 ratings generated profit
0%
Average Return
-59.81%

Copying Stacy Ku's trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -59.81% per trade.

VRCA Analyst Recommendation Trends

02468Nov 25Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26
Monthly rating counts for VRCA
RatingJun 26Jul 26Aug 26Sep 26Oct 26
Strong Buy34363
Buy00000
Hold12220
Sell00000
Strong Sell00000
total46583

In the current month, VRCA has received 3 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. VRCA average Analyst price target in the past 3 months is 13.67.

VRCA Financial Forecast

$-2$-1.5$-1$-0.5$0Q4 2025Q2 2026Q3 2026
High$-0.38
Consensus$-0.50
Low$-0.61

VRCA Earnings Forecast

Next quarter’s earnings estimate for VRCA is -$0.50 with a range of -$0.61 to -$0.38. The previous quarter’s EPS was -$0.62. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.

$5M$7.4M$9.7M$12M$14.3MQ4 2025Q2 2026Q3 2026
High$7.5M
Consensus$6.2M
Low$5.3M

VRCA Sales Forecast

Next quarter’s sales forecast for VRCA is $6.20M with a range of $5.30M to $7.50M. The previous quarter’s sales results were $5.86M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

VRCA Stock Forecast FAQ

What is VRCA’s average 12-month price target, according to analysts?
Based on analyst ratings, Verrica Pharmaceuticals’s 12-month average price target is $13.67.
What is VRCA’s upside potential, based on the analysts’ average price target?
Verrica Pharmaceuticals has 315.40% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is VRCA a Buy, Sell or Hold?
Verrica Pharmaceuticals has a consensus rating of Strong Buy which is based on 3 buy ratings, 1 hold ratings and 0 sell ratings.
What is Verrica Pharmaceuticals’s price target?
The average price target for Verrica Pharmaceuticals is $13.67. This is based on 4 12-month price targets, issued in the past 3 months. The highest analyst price target is $20.00, the lowest forecast is $9.00. The average price target represents a 315.40% increase from the current price of $3.29.
What do analysts say about Verrica Pharmaceuticals?
Verrica Pharmaceuticals’s analyst rating consensus is a Strong Buy. This is based on the ratings of 4 Wall Street analysts.
How can I buy shares of VRCA?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.